Effect of ultrasound-guided superior laryngeal nerve block on the response to awake nasal tracheal intubation in patients with COPD

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040185

Enrollment

Unknown

Registered

2020-11-24

Start date

2020-11-26

Completion date

Unknown

Last updated

2021-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Failure

Interventions

Experimental group:superior laryngeal nerve block

Control Group:No

Eligibility

Sex/Gender

All

Age

35 Years to 85 Years

Inclusion criteria

Inclusion criteria: The Patients with COPD need awake nasal tracheal intubation35-85 years old ASA II-IV

Exclusion criteria

Exclusion criteria: Contraindications of regional block; history of severe hypertension or heart disease; severe liver and kidney insufficiency; blood system diseases and abnormal bleeding and coagulation; recent use of analgesics; history of the drugs allergy or contraindications; history of head, neck, maxillofacial, oral and airway surgery

Design outcomes

Primary

Measure	Time frame
N;NE;	—

Secondary

Measure	Time frame
mean arterial pressure;heart rate;Comfort score during intubation;Tolerance score after intubation;Time of successful intubation;	—

Countries

China

Contacts

Public ContactLiu Dongyi

The Second Hospital of Shandong University

dyjn2011@126.com+86 17660085565

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026